ACADIA PHARMACEUTICALS INC (ACAD) Stock Earnings Estimates
NASDAQ:ACAD • US0042251084
22.03 USD
+0.42 (+1.94%)
At close: Feb 13, 2026
22.03 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -1.239M -100.26% | -2.445M -97.38% | -804K 67.12% | 1.103B 137,289.05% | 1.227B 11.24% | 1.354B 10.35% | 1.472B 8.71% | 1.634B 11.01% | 1.826B 11.75% | 2.093B 14.62% | 2.197B 4.97% | 1.6B -27.17% | |
| EBITDA YoY % growth | 297K 100.18% | 2.63M 785.52% | 14.387M 447.03% | 120.9M 740.34% | 143.84M 18.97% | 233.02M 62.00% | 597.24M 156.30% | 711.66M 19.16% | 1.107B 55.55% | 839.66M -24.15% | 1.078B 28.39% | 646.88M -39.99% | |
| EBIT YoY % growth | -1.733M 98.98% | -2.922M -68.61% | -1.496M 48.80% | 111.42M 7,547.86% | 143.79M 29.05% | 222.8M 54.95% | 338.33M 51.85% | 498.91M 47.46% | 620.2M 24.31% | 734.6M 18.45% | 924.42M 25.84% | 675.48M -26.93% | |
| Operating Margin | 139.90% | 119.51% | 186.07% | 10.10% | 11.72% | 16.45% | 22.98% | 30.53% | 33.96% | 35.10% | 42.08% | 42.22% | |
| EPS YoY % growth | -0.97 7.62% | -0.38 60.82% | 0.48 226.32% | 0.82 70.03% | 0.77 -6.27% | 1.14 48.99% | 1.98 73.61% | 2.53 27.69% | 2.98 18.12% | 3.29 10.28% | 4.29 30.27% | 3.03 -29.22% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.13 770.24% | 0.12 13.13% | 0.18 14.75% | 0.22 -48.51% | 0.23 75.01% |
| Revenue Q2Q % growth | 299M 15.18% | 288.77M 18.19% | 310.82M 17.48% | 331.11M 18.83% | 351.39M 17.52% |
| EBITDA Q2Q % growth | 28.286M 23.68% | 8.399M -62.24% | 28.147M -26.43% | 36.988M -17.05% | 42.024M 48.57% |
| EBIT Q2Q % growth | 23.295M 233.36% | 29.007M 50.37% | 37.749M 16.60% | 46.048M 28.78% | 56.355M 141.92% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.42 110.00% | 0.15 | 0.27 | 178.22% |
| Q2 2025 Q2Q % growth | 0.16 -20.00% | 0.14 | 0.02 | 14.46% |
| Q1 2025 Q2Q % growth | 0.11 10.00% | 0.11 | 0.00 | -3.19% |
| Q4 2024 Q2Q % growth | -0.02 -107.14% | 0.22 | -0.24 | -109.07% |
| Q3 2024 Q2Q % growth | 0.20 150.00% | 0.14 | 0.06 | 41.97% |
| Q2 2024 Q2Q % growth | 0.20 1,900.00% | 0.18 | 0.02 | 9.83% |
| Q1 2024 Q2Q % growth | 0.10 137.04% | 0.05 | 0.05 | 109.49% |
| Q4 2023 Q2Q % growth | 0.28 207.69% | 0.31 | -0.03 | -9.66% |
| Q3 2023 Q2Q % growth | -0.40 -135.29% | -0.43 | 0.03 | 7.97% |
| Q2 2023 Q2Q % growth | 0.01 104.76% | -0.08 | 0.09 | 111.87% |
| Q1 2023 Q2Q % growth | -0.27 18.18% | -0.22 | -0.05 | -23.29% |
| Q4 2022 Q2Q % growth | -0.26 3.70% | -0.25 | -0.01 | -4.94% |
| Q3 2022 Q2Q % growth | -0.17 -88.89% | -0.19 | 0.02 | 12.05% |
| Q2 2022 Q2Q % growth | -0.21 22.22% | -0.25 | 0.04 | 16.87% |
| Q1 2022 Q2Q % growth | -0.33 21.43% | -0.61 | 0.28 | 46.18% |
| Q4 2021 Q2Q % growth | -0.27 35.71% | -0.24 | -0.03 | -11.34% |
| Q3 2021 Q2Q % growth | -0.09 83.33% | -0.27 | 0.18 | 66.19% |
| Q2 2021 Q2Q % growth | -0.27 | -0.31 | 0.04 | 13.13% |
| Q1 2021 Q2Q % growth | -0.42 26.32% | -0.54 | 0.12 | 22.52% |
| Q4 2020 Q2Q % growth | -0.42 | -0.48 | 0.06 | 12.68% |
| Q3 2020 Q2Q % growth | -0.54 | -0.39 | -0.15 | -38.11% |
| Q2 2020 Q2Q % growth | -0.27 | -0.45 | 0.18 | 40.17% |
| Q1 2020 Q2Q % growth | -0.57 | -0.49 | -0.08 | -16.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 278.633M 11.27% | 282M | -3.367M | -1.19% |
| Q2 2025 Q2Q % growth | 264.566M 9.34% | 267.05M | -2.484M | -0.93% |
| Q1 2025 Q2Q % growth | 244.317M 18.70% | 244.12M | 197K | 0.08% |
| Q4 2024 Q2Q % growth | 259.602M 12.36% | 283.2M | -23.598M | -8.33% |
| Q3 2024 Q2Q % growth | 250.401M 18.28% | 253.79M | -3.389M | -1.34% |
| Q2 2024 Q2Q % growth | 241.963M 46.44% | 240.37M | 1.593M | 0.66% |
| Q1 2024 Q2Q % growth | 205.831M 73.75% | 212.46M | -6.629M | -3.12% |
| Q4 2023 Q2Q % growth | 231.041M 69.26% | 228.26M | 2.781M | 1.22% |
| Q3 2023 Q2Q % growth | 211.699M 61.97% | 193.28M | 18.419M | 9.53% |
| Q2 2023 Q2Q % growth | 165.235M 22.76% | 160.96M | 4.275M | 2.66% |
| Q1 2023 Q2Q % growth | 118.462M 2.56% | 122.69M | -4.228M | -3.45% |
| Q4 2022 Q2Q % growth | 136.5M 4.36% | 136.75M | -250K | -0.18% |
| Q3 2022 Q2Q % growth | 130.7M -0.68% | 141.42M | -10.72M | -7.58% |
| Q2 2022 Q2Q % growth | 134.6M 16.84% | 133.04M | 1.56M | 1.17% |
| Q1 2022 Q2Q % growth | 115.5M 8.35% | 124.35M | -8.85M | -7.12% |
| Q4 2021 Q2Q % growth | 130.8M 8.10% | 138.1M | -7.3M | -5.29% |
| Q3 2021 Q2Q % growth | 131.6M 9.12% | 130.31M | 1.29M | 0.99% |
| Q2 2021 Q2Q % growth | 115.2M 4.63% | 127.44M | -12.24M | -9.60% |
| Q1 2021 Q2Q % growth | 106.6M 18.31% | 113.87M | -7.27M | -6.38% |
| Q4 2020 Q2Q % growth | 121M | 125.67M | -4.67M | -3.72% |
| Q3 2020 Q2Q % growth | 120.6M | 121.2M | -600K | -0.50% |
| Q2 2020 Q2Q % growth | 110.1M | 105.41M | 4.69M | 4.45% |
| Q1 2020 Q2Q % growth | 90.1M | 92.894M | -2.794M | -3.01% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.32% | 0.52% | -0.91% | 39.89% |
| Revenue | -0.03% | 0.62% | 0% | 0.91% |